Is Krystal Biotech, Inc. KRYS stock halal to invest in?

No, as of February 2026, Krystal Biotech, Inc. stock (KRYS) is currently categorized as NOT Shariah Compliant. The company's status is determined by a rigorous financial screening process, which uses the criteria set by the AAOIFI (Accounting and Auditing Organization for Islamic Financial Institutions) as the primary global standard for Islamic investing. Krystal Biotech, Inc. has been assessed to have exceeded the permissible financial thresholds—specifically in areas like interest-bearing debt or non-permissible income (such as income from interest)—and, therefore, does not qualify as a halal investment under the current review. For investors seeking Shariah compliant global stocks, it is essential to check the latest compliance status, as these screenings are updated regularly (e.g., monthly) or upon the release of new financial reports. You can find the most current status for Krystal Biotech, Inc. and alternative halal stock options within the Tabadulat app.

How often is Krystal Biotech, Inc. KRYS reviewed for Shariah compliance?

At Tabadulat, we receive Shariah compliance data on Krystal Biotech, Inc. KRYS monthly. We apply the rigorous AAOIFI screening methodology under the direct supervision of our dedicated Shariah Supervisory Board to ensure your investments are consistently compliant.

Does Krystal Biotech, Inc. KRYS pass the AAOIFI Non Permissible Income criteria?

No, as of February 2026, Krystal Biotech, Inc. stock (KRYS) does not pass the AAOIFI Non Permissible Income criterion. The company's income from non-permissible sources has exceeded the permissible threshold set by AAOIFI, indicating the stock is currently not Shariah compliant for this screen.

Does Krystal Biotech, Inc. KRYS pass the AAOIFI Interest Bearing Investments criteria?

Yes, as of February 2026, Krystal Biotech, Inc. stock (KRYS) passes the AAOIFI Interest Bearing Investments criterion. The company's interest-bearing investments are below the acceptable threshold set by AAOIFI.

Does STOCK pass the AAOIFI Interest Bearing Debt criteria?

Yes, as of February 2026, Krystal Biotech, Inc. stock (KRYS) passes the AAOIFI Interest Bearing Debt criterion. The company's interest-bearing debt is below the acceptable threshold set by AAOIFI.

English

العربية

كن أول من يعرف

انضم إلى قائمة الانتظار لدينا للوصول المبكر والحصري إلى منصة تداول تبادلات المتوافقة مع الشريعة الإسلامية. احصل على إشعار عند إطلاق المنصة وابدأ الاستثمار بثقة.

Krystal Biotech, Inc.

NASDAQ

متوافق مع الشريعة

ليست الشريعة

KRYS

About

Krystal Biotech, Inc.

KRYS

Krystal Biotech Inc. is a biotechnology company primarily focused on developing and commercializing gene therapy products for patients with rare dermatological conditions. Its innovative platform harnesses gene delivery technology to address unmet medical needs by developing a pipeline of products aimed at treating genetic skin diseases. Krystal Biotech’s key asset is its proprietary STAR-D platform, which allows for the non-viral delivery of therapeutic genes directly into the skin. This platform exemplifies the company's commitment to deploying cutting-edge science to improve patient outcomes. The company primarily impacts the healthcare and biotechnology sectors, seeking to revolutionize treatments for genetic disorders. Incorporated in 2016 and headquartered in Pittsburgh, Pennsylvania, Krystal Biotech plays a significant role in advancing therapeutic options within the niche market of dermatological diseases, thereby positioning itself as a transformative player in gene therapy and medical research.

القطاع:

Healthcare

الصناعة:

Biotechnology

الموظفون:

275

الموقع الإلكتروني:

https://www.krystalbio.com

KRYS

Frequently asked questions

Related stocks

Mobile login screen for Tabadulat with fields to enter email, a Continue button, an option to create an account, and a language selector showing EN.

Step 1

Sign Up.

Begin by creating your Tabadulat account. Simply enter your details and complete the verification process. You’ll be up and running in no time.

Mobile screen showing add money interface with 100 AED amount and Manual Bank Transfer payment method selected, noting 1-2 business days processing.

Step 2

Deposit.

Add funds to your account using a secure payment method. You can deposit in multiple currencies to get started.

Step 3

Screen.

Screen Stocks for Free and explore a wide range of stocks that are ethically screened for Shariah compliance. Use our Halal Stock Screener to find the best opportunities.

Step 4

Trade.

Once you’ve chosen the right stocks, simply place your trades. Our platform offers real-time market data and seamless execution.

Mobile screen showing investment portfolio with $100,000 total value, $48,000 invested, and a $2,000 return (4.50%) with a line graph and options for 1W, 1M, 3M, YTD, 1Y, Max, plus Trade and Deposit buttons.

Step 5

Track.

Track your Portfolio and monitor your investments with our easy-to-use dashboard. View your portfolio performance, manage assets, and make adjustments as needed.

Step 6

Withdraw.

When you're ready, withdraw your funds quickly and securely to your bank account.

Krystal Biotech, Inc.

About

Krystal Biotech, Inc.

KRYS

Frequently asked questions

Is Krystal Biotech, Inc. KRYS stock halal to invest in?

How often is Krystal Biotech, Inc. KRYS reviewed for Shariah compliance?

Does Krystal Biotech, Inc. KRYS pass the AAOIFI Non Permissible Income criteria?

Does Krystal Biotech, Inc. KRYS pass the AAOIFI Interest Bearing Investments criteria?

Does STOCK pass the AAOIFI Interest Bearing Debt criteria?

How do I buy Krystal Biotech, Inc. KRYS stock?

Sign Up.

Deposit.

Screen.

Trade.

Track.

Withdraw.